Showing results (1871-1880 of 2,010) with videos related to
Sort By:
Pageof 201
The Pharmacogenomics Journal|February 12, 2014
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patientsF Loupakis, C Antoniotti, C Cremolini, et al.The Analyst|August 23, 2023
Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarraysBatuhan Birol Keskin, Shih-Feng Liu, Pin-Xian Du, et al.Oncogene|May 6, 2020
Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.Journal of Proteome Research|December 16, 2010
Use of proteomic differential displays to assess functional discrepancies and adjustments of human bone marrow- and Wharton jelly-derived mesenchymal stem cellsHsing-Chun Kuo, Chi-Chin Chiu, Wan-Ching Chang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2015
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trialsY Sunakawa, S Stintzing, S Cao, et al.Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.British Journal of Cancer|May 6, 2015
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resectionM Schirripa, F Bergamo, C Cremolini, et al.The Pharmacogenomics Journal|June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancerY Sunakawa, S Cao, N B Volz, et al.Proteomics|July 14, 2011
Identification of immunodeficient molecules in neonatal mononuclear cells by proteomic differential displaysHong-Ren Yu, Hsing-Chun Kuo, Hsin-Chun Huang, et al.The Pharmacogenomics Journal|April 12, 2017
Prognostic impact of FOXF1 polymorphisms in gastric cancer patientsS Matsusaka, A H Wu, S Cao, et al.Pageof 201